ARC-12
Phase 1 Completed
94 enrolled
ROOT
Completed
167 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Phase 1/2 Unknown
73 enrolled
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
Phase 1 Completed
22 enrolled
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Phase 2 Completed
185 enrolled
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Phase 1 Terminated
155 enrolled
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Phase 1/2 Completed
70 enrolled
BAY1238097, First in Man
Phase 1 Terminated
8 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts